151 related articles for article (PubMed ID: 23422951)
21. Methylenetetrahydrofolate reductase C677T polymorphism in patients with gastric and colorectal cancer.
Zeybek U; Yaylim I; Yilmaz H; Ağaçhan B; Ergen A; Arikan S; Bayrak S; Isbir T
Cell Biochem Funct; 2007; 25(4):419-22. PubMed ID: 16927418
[TBL] [Abstract][Full Text] [Related]
22. The association of polymorphisms in folate-metabolizing genes with response to adjuvant chemotherapy of colorectal cancer.
Yousef AM; Zawiah M; Al-Yacoub S; Kadi T; Tantawi DA; Al-Ramadhani H
Cancer Chemother Pharmacol; 2018 Aug; 82(2):237-243. PubMed ID: 29845393
[TBL] [Abstract][Full Text] [Related]
23. Association of the MTHFR Gene C677T Polymorphism with Breast Cancer in a Turkish Population.
Kaya EF; Karakus N; Ulusoy AN; Özaslan C; Kara N
Oncol Res Treat; 2016; 39(9):534-8. PubMed ID: 27614738
[TBL] [Abstract][Full Text] [Related]
24. Methylenetetrahydrofolate reductase C677T mutation in patients with alopecia areata in Turkish population.
Kalkan G; Yigit S; Karakuş N; Ateş O; Bozkurt N; Ozdemir A; Pancar GŞ
Gene; 2013 Nov; 530(1):109-12. PubMed ID: 23954881
[TBL] [Abstract][Full Text] [Related]
25. Influence of methylenetetrahydrofolate reductase gene polymorphisms C677T and A1298C on age-associated risk for colorectal cancer in a caucasian lynch syndrome population.
Pande M; Chen J; Amos CI; Lynch PM; Broaddus R; Frazier ML
Cancer Epidemiol Biomarkers Prev; 2007 Sep; 16(9):1753-9. PubMed ID: 17855693
[TBL] [Abstract][Full Text] [Related]
26. Association of the maternal MTHFR C677T polymorphism with susceptibility to neural tube defects in offsprings: evidence from 25 case-control studies.
Yan L; Zhao L; Long Y; Zou P; Ji G; Gu A; Zhao P
PLoS One; 2012; 7(10):e41689. PubMed ID: 23056169
[TBL] [Abstract][Full Text] [Related]
27. Quantitative assessment of the associations between MTHFR C677T and A1298C polymorphisms and risk of fractures: a meta-analysis.
Bai R; Liu W; Zhao A; Zhao Z; Jiang D
Mol Biol Rep; 2013 Mar; 40(3):2419-30. PubMed ID: 23229495
[TBL] [Abstract][Full Text] [Related]
28. The 677C>T (rs1801133) polymorphism in the MTHFR gene contributes to colorectal cancer risk: a meta-analysis based on 71 research studies.
Teng Z; Wang L; Cai S; Yu P; Wang J; Gong J; Liu Y
PLoS One; 2013; 8(2):e55332. PubMed ID: 23437053
[TBL] [Abstract][Full Text] [Related]
29. Interactions between genetic variants involved in the folate metabolic pathway and serum lipid, homocysteine levels on the risk of recurrent spontaneous abortion.
Lin Z; Li Q; Sun Y; Huang J; Wang W; Fu J; Xu J; Zeng D
Lipids Health Dis; 2019 Jun; 18(1):143. PubMed ID: 31200713
[TBL] [Abstract][Full Text] [Related]
30. Genetic polymorphisms of the methylenetetrahydrofolate reductase gene, plasma folate levels and breast cancer susceptibility: a case-control study in Taiwan.
Chou YC; Wu MH; Yu JC; Lee MS; Yang T; Shih HL; Wu TY; Sun CA
Carcinogenesis; 2006 Nov; 27(11):2295-300. PubMed ID: 16777985
[TBL] [Abstract][Full Text] [Related]
31. MTHFR C677T has differential influence on risk of MSI and MSS colorectal cancer.
Hubner RA; Lubbe S; Chandler I; Houlston RS
Hum Mol Genet; 2007 May; 16(9):1072-7. PubMed ID: 17350979
[TBL] [Abstract][Full Text] [Related]
32. Gene polymorphisms involved in folate and methionine metabolism and increased risk of sporadic colorectal adenocarcinoma.
Guimarães JL; Ayrizono Mde L; Coy CS; Lima CS
Tumour Biol; 2011 Oct; 32(5):853-61. PubMed ID: 21603981
[TBL] [Abstract][Full Text] [Related]
33. Methylenetetrahydrofolate reductase (MTHFR) C677T gene polymorphism and diabetic nephropathy susceptibility in patients with type 2 diabetes mellitus.
Zhou TB; Drummen GP; Jiang ZP; Li HY
Ren Fail; 2015; 37(8):1247-59. PubMed ID: 26161693
[TBL] [Abstract][Full Text] [Related]
34. Variant alleles in factor V, prothrombin, plasminogen activator inhibitor-1, methylenetetrahydrofolate reductase and risk of thromboembolism in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab.
Falvella FS; Cremolini C; Miceli R; Nichetti F; Cheli S; Antoniotti C; Infante G; Martinetti A; Marmorino F; Sottotetti E; Berenato R; Caporale M; Colombo A; de Braud F; Di Bartolomeo M; Clementi E; Loupakis F; Pietrantonio F
Pharmacogenomics J; 2017 Jul; 17(4):331-336. PubMed ID: 27001121
[TBL] [Abstract][Full Text] [Related]
35. Lack of association between the C677T MTHFR polymorphism and colorectal hyperplastic polyps.
Ulrich CM; Kampman E; Bigler J; Schwartz SM; Chen C; Bostick R; Fosdick L; Beresford SA; Yasui Y; Potter JD
Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):427-33. PubMed ID: 10794488
[TBL] [Abstract][Full Text] [Related]
36. The MTHFR C677T polymorphism and colorectal cancer: the multiethnic cohort study.
Le Marchand L; Wilkens LR; Kolonel LN; Henderson BE
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1198-203. PubMed ID: 15894672
[TBL] [Abstract][Full Text] [Related]
37. A polymorphism in the methylenetetrahydrofolate reductase gene predisposes to colorectal cancers with microsatellite instability.
Shannon B; Gnanasampanthan S; Beilby J; Iacopetta B
Gut; 2002 Apr; 50(4):520-4. PubMed ID: 11889073
[TBL] [Abstract][Full Text] [Related]
38. Genetic polymorphisms of methylenetetrahydrofolate reductase and susceptibility to colorectal cancer.
Cao HX; Gao CM; Takezaki T; Wu JZ; Ding JH; Liu YT; Li SP; Su P; Cao J; Hamajima N; Tajima K
Asian Pac J Cancer Prev; 2008; 9(2):203-8. PubMed ID: 18712959
[TBL] [Abstract][Full Text] [Related]
39. Methylenetetrahydrofolate reductase C677T polymorphism in patients with lung cancer in a Korean population.
Cui LH; Shin MH; Kim HN; Song HR; Piao JM; Kweon SS; Choi JS; Yun WJ; Kim YC; Oh IJ; Kim KS
BMC Med Genet; 2011 Feb; 12():28. PubMed ID: 21342495
[TBL] [Abstract][Full Text] [Related]
40. 5,10-Methylenetetrahydrofolate reductase C677T gene polymorphism in Behcet's patients with or without ocular involvement.
Ozkul Y; Evereklioglu C; Borlu M; Taheri S; Calis M; Dündar M; Ilhan O
Br J Ophthalmol; 2005 Dec; 89(12):1634-7. PubMed ID: 16299146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
